申请人:Pfizer Products Inc.
                            
                            
                                公开号:EP1241176A1
                            
                            
                                公开(公告)日:2002-09-18
                            
                            
A3 agonists having Formula I are described herein as well as methods of using such A3 agonists and pharmaceutical compositions containing such A3 agonists.
 The A3 agonists are useful for the reduction of tissue damage resulting from tissue ischemia or hypoxia.
                            本文描述了具有式 I 的 A3 激动剂以及使用这种 A3 激动剂的方法和含有这种 A3 激动剂的药物组合物。
 A3 激动剂可用于减少组织缺血或缺氧造成的组织损伤。